Adult congenital heart disease: Looking back, moving forward

Adult congenital heart disease: Looking back, moving forward

Advances in congenital heart disease (CHD) have changed radically the prognosis and burden of the disease. The vast majority of patients survive into adulthood and their profile in terms of comorbidities has changed. Organisation of tertiary and non-tertiary care, collaboration at national and inter...

Full description

Bibliographic Details
Main Authors: Despoina Ntiloudi, Michael A. Gatzoulis, Alexandra Arvanitaki, Haralambos Karvounis, George Giannakoulas
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Cardiology Congenital Heart Disease
Subjects:
Adult congenital heart disease
Biobanking
e-health
Artificial intelligence
Online Access:http://www.sciencedirect.com/science/article/pii/S2666668520300768
id doaj-bd6f81f67aa14abeb90e0b9dac5cc209
record_format Article
spelling doaj-bd6f81f67aa14abeb90e0b9dac5cc2092021-06-07T07:07:28ZengElsevierInternational Journal of Cardiology Congenital Heart Disease2666-66852021-02-012100076Adult congenital heart disease: Looking back, moving forwardDespoina Ntiloudi0Michael A. Gatzoulis1Alexandra Arvanitaki2Haralambos Karvounis3George Giannakoulas4Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceAdult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, United KingdomCardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London, United Kingdom; Department of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149, Muenster, GermanyCardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, GreeceCardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; Corresponding author. St. Kyriakidi str 1, 54636, Thessaloniki, Greece.Advances in congenital heart disease (CHD) have changed radically the prognosis and burden of the disease. The vast majority of patients survive into adulthood and their profile in terms of comorbidities has changed. Organisation of tertiary and non-tertiary care, collaboration at national and international level, randomised controlled trials and implementation of novelties, such as research based biobanking, e-health and artificial intelligence should all be employed to meet their healthcare needs.http://www.sciencedirect.com/science/article/pii/S2666668520300768Adult congenital heart diseaseBiobankinge-healthArtificial intelligence
collection DOAJ
language English
format Article
sources DOAJ
author Despoina Ntiloudi
Michael A. Gatzoulis
Alexandra Arvanitaki
Haralambos Karvounis
George Giannakoulas
spellingShingle Despoina Ntiloudi
Michael A. Gatzoulis
Alexandra Arvanitaki
Haralambos Karvounis
George Giannakoulas
Adult congenital heart disease: Looking back, moving forward
International Journal of Cardiology Congenital Heart Disease
Adult congenital heart disease
Biobanking
e-health
Artificial intelligence
author_facet Despoina Ntiloudi
Michael A. Gatzoulis
Alexandra Arvanitaki
Haralambos Karvounis
George Giannakoulas
author_sort Despoina Ntiloudi
title Adult congenital heart disease: Looking back, moving forward
title_short Adult congenital heart disease: Looking back, moving forward
title_full Adult congenital heart disease: Looking back, moving forward
title_fullStr Adult congenital heart disease: Looking back, moving forward
title_full_unstemmed Adult congenital heart disease: Looking back, moving forward
title_sort adult congenital heart disease: looking back, moving forward
publisher Elsevier
series International Journal of Cardiology Congenital Heart Disease
issn 2666-6685
publishDate 2021-02-01
description Advances in congenital heart disease (CHD) have changed radically the prognosis and burden of the disease. The vast majority of patients survive into adulthood and their profile in terms of comorbidities has changed. Organisation of tertiary and non-tertiary care, collaboration at national and international level, randomised controlled trials and implementation of novelties, such as research based biobanking, e-health and artificial intelligence should all be employed to meet their healthcare needs.
topic Adult congenital heart disease
Biobanking
e-health
Artificial intelligence
url http://www.sciencedirect.com/science/article/pii/S2666668520300768
work_keys_str_mv AT despoinantiloudi adultcongenitalheartdiseaselookingbackmovingforward
AT michaelagatzoulis adultcongenitalheartdiseaselookingbackmovingforward
AT alexandraarvanitaki adultcongenitalheartdiseaselookingbackmovingforward
AT haralamboskarvounis adultcongenitalheartdiseaselookingbackmovingforward
AT georgegiannakoulas adultcongenitalheartdiseaselookingbackmovingforward
_version_ 1721391530571202560

Similar Items